These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 12130763

  • 1. Women's health. The vanishing promises of hormone replacement.
    Enserink M.
    Science; 2002 Jul 19; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract] [Full Text] [Related]

  • 2. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.
    Am J Epidemiol; 2009 Jul 01; 170(1):12-23. PubMed ID: 19468079
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 01; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
    Shapiro S.
    Climacteric; 2003 Dec 01; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A clinician's review of the WHI-related literature.
    Speroff L.
    Int J Fertil Womens Med; 2004 Dec 01; 49(6):252-67. PubMed ID: 15751264
    [Abstract] [Full Text] [Related]

  • 15. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL.
    J Am Osteopath Assoc; 2003 Feb 01; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Statement on results of the HERS II trial on hormone replacement therapy.
    American College of Obstetricians and Gynecologists.
    Ginecol Obstet Mex; 2002 Aug 01; 70():406-8. PubMed ID: 12448046
    [No Abstract] [Full Text] [Related]

  • 18. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002 Aug 01; 8(5):27. PubMed ID: 12233798
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.